Publications by authors named "Po Yee Yip"

Claim this Profile
H
Histopathological associations, molecular findings and clinical outcomes of patients with non-small cell lung carcinoma with MET alterations: a 3-year retrospective Australian case series.
Jing Jing Li, Jawad Saab, Victoria Bray, Jonathan Williamson, Abhijit Pal, Po Yee Yip

Pathology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping Smoking.
Alison Luk Young, Melissa McEnallay, Fiona Day, Shalini K Vinod, Emily Stone, Po Yee Yip

Asia Pac J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Survival Outcomes of Patients With High PD-L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy.
Junipearl Cheng, Charlotte McKay, Victoria Bray, Po Yee Yip, Annette Tognela

Asia Pac J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and When.
Alison Luk Young, Melissa McEnallay, Fiona Day, Shalini K Vinod, Emily Stone, Po Yee Yip

Asia Pac J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma.
Jing Jing Li, Xiao Juan Wu, Mahtab Farzin, Victoria Bray, Jonathan Williamson, Po Yee Yip

Pathology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance.
Malinda Itchins, Shirley Liang, Chris Brown, Tristan Barnes, Gavin Marx, Po Yee Yip

JTO Clin Res Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso.
Nicholas McNamee, Catriona Harvey, Lauren Gray, Trisha Khoo, Lavanya Lingam, Po Yee Yip

J Thorac Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer.
Samuel Stevens, Udit Nindra, Adel Shahnam, Joe Wei, Victoria Bray, Po Yee Yip

J Geriatr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab.
Udit Nindra, Adel Shahnam, Samuel Stevens, Abhijit Pal, Adnan Nagrial, Po Yee Yip

Asia Pac J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of extensive stage extrapulmonary small cell cancer.
Geovanny Gandy, Po Yee Yip, Annette Tognela, Faisal Hayat, William Fox

Intern Med J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases.
Malinda Itchins, Hannah Ainsworth, Marliese Alexander, Samantha Dean, Devi Dharmaraj, Po Yee Yip

Clin Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumab.
Udit Nindra, Adel Shahnam, Samuel Stevens, Abhijit Pal, Adnan Nagrial, Po Yee Yip

Thorac Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population.
Tamkin Ahmadzada, Wendy A Cooper, Mikaela Holmes, Annabelle Mahar, Helen Westman, Po Yee Yip

JTO Clin Res Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.
Wendy A Cooper, Thang Tran, Ricardo E Vilain, Jason Madore, Christina I Selinger, PoYee Yip

Lung Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer.
Po Yee Yip

Transl Lung Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.
Annette Tognela, Kevin J Spring, Therese Becker, Nicole J Caixeiro, Victoria J Bray, Po Yee Yip

Crit Rev Oncol Hematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.
Po Yee Yip, Bing Yu, Wendy A Cooper, Christina I Selinger, Chiu Chin Ng

J Thorac Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.
Po Yee Yip, James G Kench, Krishan K Rasiah, Ruth Pe Benito, C-Soon Lee

Prostate· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem termination signals: myth or reality?
Louise L Major, Tina D Edgar, Po Yee Yip, Leif A Isaksson, Warren P Tate

FEBS Lett· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis